Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Long-Term Debt Repayments (2020 - 2023)

Neuronetics (STIM) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $1.2 million as the latest value for Q1 2023.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $1.2 million in Q1 2023 year-over-year; TTM through Dec 2023 was $1.2 million, a N/A change, with the full-year FY2024 number at $60.0 million, up 4900.0% from a year prior.
  • Long-Term Debt Repayments was $1.2 million for Q1 2023 at Neuronetics, down from $6.4 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $32.5 million in Q1 2020 to a low of $1.2 million in Q1 2023.